-
I just swung
$DNLI like the setup .. for all you biotech people. -
$TAK earnings AH likely to see Qs on how they will catch up in#Genetherapy. Admit to being behind in HemA HemB but focus on nextgen AAV with redosing. Biggest focus#CNS with$wave lagging and$DNLI progressing. M&A in C20 to catchup? https://www.biopharmadive.com/news/takeda-car-t-gene-therapy-research-andy-plump/567640/ … -
Interesting for
$dnli investors, among others. -
Denali Therapeutics Inc
$DNLI Expected to Earn Q1 2020 Earnings of -$0.62 Per Share http://baseballnewssource.com/?p=3934511 -
$DNLI closes public offering of 9,000,000 shares of its common stock at $23.00 per share#DenaliTherapeutics http://crweworld.com/symbol/DNLI -
Equities Analysts Offer Predictions for Denali Therapeutics Inc’s FY2024 Earnings
$DNLI http://zolmax.com/?p=3609003 -
$DNLI breaking down through deal price. Prospectus adds that company now having to conduct chronic tox studies to decide which one of -201 or -151 to progress. Safety issues or FDA request? Note LRRK2 has been theorized to cause lung tox - https://www.ncbi.nlm.nih.gov/pubmed/25653221 pic.twitter.com/kHyng6nfc1
-
-
Tale of 2
$TAK#CNS partners.$DNLI is rolling.$WVE is reelingpic.twitter.com/jdw0FhfRA6
Prikaži ovu nit -
$DNLI#Denali Therapeutics Inc With All Efforts On Track, DNLI Prices Offering: | http://dlvr.it/RP0658#equity#stockspic.twitter.com/nqW0qr3HPe
-
$DNLI What happened??? why the bounce?? 6.68 % change recently https://blueequity.io/symbol/DNLI -
-
$BDSI$GILD$GH$DNLI: Gilead’s Mantle Cell Lymphoma Drug MAA Gets EMA Validation: https://www.StockNewsWires.com/bdsi-gild-gh-dnli-gileads-mantle-cell-lymphoma-drug-maa-gets-ema-validation/ … -
$DNLI declines in premarket trading. See the latest news. https://marketchameleon.com/Overview/DNLI/Summary/ …pic.twitter.com/Yb0V8wMEcY
-
Biotech updates 01/27
$XLRN data +68% AH$PRNB report -10%$LLY$MRK FDA Approvals$ALEC$CNCE$DNLI offerings$CBLI +211%;$INO +25%;$VIR; +24%;$CDTX +23%#coronavirus spec movers Pipe updates$AVEO$AVXL$AZN$CBIO$INCY$LQDA$NCNA$RHHBY$SURF$TROVhttps://www.biopharmcatalyst.com/news/2020/acceleron-xlrn-shares-surge-68-on-positive-data-principia-prnb-shares-fall-10-on-short-report …
Čini se da učitavanje traje već neko vrijeme.
Twitter je možda preopterećen ili ima kratkotrajnih poteškoća u radu. Pokušajte ponovno ili potražite dodatne informacije u odjeljku Status Twittera.